When was Sarmal founded?

Sarmal was founded in 2003 and raised its 1st funding round 22 years after it was founded.

Where is Sarmal located?

Sarmal is headquartered in San Diego, United States.

How many employees does Sarmal have?

As of Apr 30, 2026, the latest employee count at Sarmal is 19.

Is Sarmal a funded company?

Sarmal is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Jun 06, 2025.

When was the latest funding round of Sarmal?

Sarmal's latest funding was a $***** Series A round on Jun 06, 2025, with participation from 0 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $632M in funding in 2026 to date.

Where does Sarmal rank among its competitors?

Sarmal ranks 177th amongst 1190 active competitors, of which 168 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Sarmal, which secured $5M in Jun, 2025.

Who are the top competitors of Sarmal?

Sarmal's top competitors include DNAnexus, Strand Life Sciences and Twin Strand Bio. Among them, Sarmal secured the most recent funding round in June, 2025.

Sarmal - 2026 Company Profile, Funding & Competitors

Sarmal is a series A company based in San Diego (United States), founded in 2003. It operates as a Developer of a next-generation genomic sequencing platform. Sarmal has raised $5M in funding. The company has 1190 active competitors, including 168 funded and 125 that have exited. Its top competitors include companies like DNAnexus, Strand Life Sciences and Twin Strand Bio.

Company Details

Developer of a next-generation genomic sequencing platform. The company has a FLASH Sequencing platform for whole-genome sequencing technology and a DeTaiL platform is a portable, field-deployable nucleic acid-based diagnostic platform.

Key Metrics

Founded Year

2003

Location

San Diego, United States

Stage

Series A

Total Funding

$5M in 1 round

Latest Funding Round

Series A, Jun 06, 2025, $*****

Investors

Mene Ventures & 1 more

Ranked

177^th among 1190 active competitors

Employee Count

19 as on Apr 30, 2026

Similar Companies

DNAnexus & 788 more

View Sarmal's full profile

Sarmal has raised a total funding of $5M over 1 round. Sarmal has 2 institutional investors.

Here is the list of recent funding rounds of Sarmal:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 06, 2025	4406024	Series A	4840811	3452049	6519801	4154485

Access funding benchmarks and valuations. Sign up today!

View details of Sarmal's funding rounds and investors

Sarmal's employee count trend

Sarmal has 19 employees as of Apr 26. Here is Sarmal's employee count trend over the years:

Uncover Sarmal's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sarmal include DNAnexus, Strand Life Sciences and Twin Strand Bio. Here is the list of Top 10 competitors of Sarmal, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	DNAnexus 2009, Mountain View (United States), Series H	Provider of cloud-based genome informatics & data management platform	$473M	Google Ventures, TPG & 21 others	70/100
2nd	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, Quadria Capital & 92 others	65/100
3rd	Twin Strand Bio 2015, Seattle (United States), Series B	Developer of DNA sequencing technology to identify genomic mutations	$84M	Madrona, S32 & 9 others	65/100
4th	Tessera Therapeutics 2017, Cambridge (United States), Series C	Provider of new genome engineering technology for treating multiple diseases	$610M	ADIA, Temasek & 22 others	64/100
5th	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Fusion Capital, Sequoia Capital China & 15 others	64/100
6th	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	SoftBank Vision Fund, Khosla Ventures & 16 others	63/100
7th	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Nextech Invest & 10 others	63/100
8th	ONCOHOST 2017, Binyamina Giv at Ada (Israel), Series C	AI-based oncology therapy plan solution for professionals	$43M	ALIVE, OurCrowd & 5 others	61/100
9th	Singular Genomics 2016, San Diego (United States), Acquired	Provider of next-generation gene sequencing and multi-omics technologies	-	Domain Associates, Perceptive Advisors & 5 others	60/100
10th	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	59/100
177th	Sarmal 2003, San Diego (United States), Series A	Developer of a next-generation genomic sequencing platform	$5M	Mene Ventures, Ophir Equity Partners	36/100